Pharmaceutical

NICE recommends Lilly’s tirzepatide to treat T2D

The UK NICE has recommended Eli Lilly’s tirzepatide for the treatment of adult patients with inadequately controlled type 2 diabetes.

Sep 9, 2023 - 20:00
NICE recommends Lilly’s tirzepatide to treat T2D
The UK NICE has recommended Eli Lilly’s tirzepatide for the treatment of adult patients with inadequately controlled type 2 diabetes.
Read the original article

Tags:

Previous Article

Otsuka and ShapeTX to develop gene therapies for eye diseases

Next Article

EC expands indication approval for Merck’s Ebola vaccine

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The new frontiers of pharmaceutical innovation – according to investors ​

The new frontiers of pharmaceutical innovation – accord...

Mar 21, 2023

STAT+: At JPM, Verve details plot to take genome editing mainstream

STAT+: At JPM, Verve details plot to take genome editin...

Jan 10, 2024

Influenza (quadrivalent) vaccine by Pfizer for Influenz...

May 17, 2024